Skip to content
Governance Register

← US public companies

Hunt Ronald

SEC-identified person · CIK 1247851 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Rallybio Corp RLYB Director filed 2021 - 2026
Iterum Therapeutics plc ITRM Director filed 2018 - 2025
Harpoon Therapeutics, Inc. HARP Director filed 2019 - 2024
Neuronetics, Inc. STIM Director filed 2018 - 2019
Irhythm Technologies, Inc. IRTC Officer filed 2016 - 2016
MEI Pharma, Inc. MSHL Officer filed 2012 - 2015
Versartis, Inc. VSAR Officer filed 2014 - 2014
Durata Therapeutics, Inc. DRTX Director filed 2012 - 2014
Chimerix INC CRMX Officer filed 2014 - 2014
Concert Pharmaceuticals, INC. N/A Officer filed 2014 - 2014
Oxford Immunotec Global PLC OXFD Officer filed 2013 - 2013
Relypsa Inc RLYP Director filed 2013 - 2013
World Heart Corp whrt Officer filed 2008 - 2012
Icagen INC ICGN Officer filed 2011 - 2011
Transcept Pharmaceuticals Inc TSPT Officer filed 2009 - 2011

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.